Asset Allocation

As of November 30, 2025.
Type % Net
Cash 1.81%
Stock 63.01%
Bond 31.66%
Convertible 0.00%
Preferred 0.00%
Other 3.52%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 83.52%
Mid 11.80%
Small 4.68%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.19%    % Emerging Markets: 0.00%    % Unidentified Markets: 1.81%

Americas 94.38%
94.11%
Canada 1.00%
United States 93.11%
0.27%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 3.58%
United Kingdom 0.95%
2.63%
France 0.09%
Ireland 1.25%
Netherlands 0.42%
Norway 0.02%
Spain 0.23%
Switzerland 0.36%
0.00%
0.00%
Greater Asia 0.23%
Japan 0.00%
0.15%
Australia 0.15%
0.09%
Singapore 0.09%
0.00%
Unidentified Region 1.81%

Bond Credit Quality Exposure

AAA 0.82%
AA 51.92%
A 8.75%
BBB 25.96%
BB 2.81%
B 0.11%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 9.63%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
26.12%
Materials
2.22%
Consumer Discretionary
9.32%
Financials
12.49%
Real Estate
2.10%
Sensitive
55.38%
Communication Services
11.06%
Energy
3.29%
Industrials
7.20%
Information Technology
33.84%
Defensive
18.50%
Consumer Staples
4.75%
Health Care
11.26%
Utilities
2.48%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 41.15%
Corporate 40.92%
Securitized 16.17%
Municipal 0.13%
Other 1.64%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.84%
Less than 1 Year
1.84%
Intermediate
54.67%
1 to 3 Years
12.11%
3 to 5 Years
21.50%
5 to 10 Years
21.05%
Long Term
43.15%
10 to 20 Years
9.71%
20 to 30 Years
32.31%
Over 30 Years
1.13%
Other
0.35%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial